Home » Authors » Glen Harris

Articles by Glen Harris

Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

No Abstract

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

No Abstract

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

No Abstract

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

No Abstract

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

No Abstract

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...